MEDI 242-Discovery and design of potent piperidine-based CCR5 antagonists for the potential treatment of HIV-1 infection

被引：0

作者：

Chauder, Brian A. ^{[1
]}

Anderson, Donald ^{[1
]}

Aquino, Christopher J. ^{[1
]}

Bifulco, Neil ^{[1
]}

Boone, Lawrence R. ^{[1
]}

Boros, Eric E. ^{[1
]}

Chong, Pek Y. ^{[1
]}

Du, Kien S. ^{[1
]}

Duan, Maosheng ^{[1
]}

Ferris, Robert G. ^{[1
]}

Kazmierski, Wieslaw M. ^{[1
]}

Kenakin, Terrence P. ^{[1
]}

Koble, Cecilia S. ^{[1
]}

Lang, Daniel G. ^{[1
]}

Peckham, Jennifer P. ^{[1
]}

Spaltenstein, Andrew ^{[1
]}

Thompson, James B. ^{[1
]}

Youngman, Michael K. ^{[1
]}

Wheelan, Patricia J. ^{[1
]}

机构：

[1] GlaxoSmithKline Res & Dev Ltd, Metab & Viral Dis CEDD, Durham, NC 27709 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 232卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

242-MEDI

引用

页数：1

共 50 条

[41] CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
Jianglin He
Youzhi Chen
Michael Farzan
Hyeryun Choe
Asa Ohagen
Suzanne Gartner
Jorge Busciglio
Xiaoyu Yang
Wolfgang Hofmann
Walter Newman
Charles R. Mackay
Joseph Sodroski
Dana Gabuzda
Nature, 1997, 385 : 645 - 649
[42] CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
He, JL
Chen, YZ
Farzan, M
Choe, HY
Ohagen, A
Gartner, S
Busciglio, J
Yang, XY
Hofmann, W
Newman, W
Mackay, CR
Sodroski, J
Gabuzda, D
NATURE, 1997, 385 (6617) : 645 - 649
[43] Effects of CCR2 and CCR5 polymorphisms on HIV-1 infection in Thai females
Wichukchinda, Nuanjun
Nakayama, Emi E.
Rojanawiwat, Archawin
Pathipvanich, Panita
Auwanit, Rattana
Vongsheree, Suthon
Ariyoshi, Koya
Sawanpanyalert, Pathom
Shioda, Tatsuo
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (03) : 293 - 297
[44] Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
Simmons, G
Clapham, PR
Picard, L
Offord, RE
Rosenkilde, MM
Schwartz, TW
Buser, R
Wells, TNC
Proudfoot, AEI
SCIENCE, 1997, 276 (5310) : 276 - 279
[45] HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization
Vila-Coro, AJ
Mellado, M
de Ana, AM
Lucas, P
del Real, G
Martinez, C
Rodriguez-Frade, JM
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3388 - 3393
[46] Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments
Imai, Masaki
Baranyi, Lajos
Okada, Noriko
Okada, Hidechika
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 353 (04) : 851 - 856
[47] Prognostic Value of a CCR5 Defective Allele in Pediatric HIV-1 Infection
Maria Luisa Romiti
Claudia Colognesi
Caterina Cancrini
Antonio Mas
Monica Berrino
Francesca Salvatori
Paola Orlandi
Marianne Jansson
Elvia Palomba
Anna Plebani
Jose M. Bertran
Manuel Hernandez
Maurizio de Martino
Antonio Amoroso
Pier Angelo Tovo
Paolo Rossi
Teresa Espanol
Gabriella Scarlatti
Molecular Medicine, 2000, 6 : 28 - 36
[48] Relationship between productive HIV-1 infection of macrophages and CCR5 utilization
Hung, CS
Pontow, S
Ratner, L
VIROLOGY, 1999, 264 (02) : 278 - 288
[49] Cenicriviroc, an orally active CCR5 antagonist for the potential treatment of HIV infection
Klibanov, Olga M.
Williams, Shannon H.
Iler, Cameron A.
CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (08) : 940 - 950
[50] CCR5 genotype and HIV-1 infection in perinatally-exposed infants
Mas, A
Español, T
Heredia, A
Pedraza, MA
Hernandez, M
Caragol, I
Fernando, M
Bertran, JM
Alcami, J
Soriano, V
JOURNAL OF INFECTION, 1999, 38 (01) : 9 - 11

← 1 2 3 4 5 →